Treatment Research Institute


collaborationAbout Us

Founded by the same researchers who developed the Addiction Severity Index, the Treatment Research Institute is an independent, nonprofit research and development organization dedicated to science-driven reform of treatment and policy in substance use.

Learn More

Featured Topic

TRI Introduces New CEO

Treatment Research Institute is pleased to introduce David R. Gastfriend, M.D. as Chief Executive Officer effective September 1, 2014. TRI is also eager to have A. Thomas McLellan, M.D. continue his role with the organization as Chair of the Board of Directors.

Dr. Gastfriend is a highly respected scientist, clinician and business leader. He brings a wealth of expertise that will help guide TRI’s growth and strengthen its impact in this era of healthcare reform.  Most recently, he served as Vice President of Scientific Communications at Alkermes Inc., where he spearheaded research, education and scientific publications on behalf of the company’s efforts in the field of addiction treatment. For more than two decades, Dr. Gastfriend served on the faculty of Harvard Medical School as the Director of the Addiction Research Program at Massachusetts General Hospital.

Learn more about Dr. Gastfriend and ongoing projects of impact at TRI.

News Headlines

David R. Gastfriend named CEO of the Treatment Research Institute; founder and current CEO, A. Thomas McLellan, becomes Chair of the Board

Philadelphia, PA (Aug. 14, 2014) – Treatment Research Institute (TRI) today announced that its Board of Directors has appointed David R. Gastfriend, M.D. as Chief Executive Officer effective September 1, 2014. Dr. Gastfriend previously held the position of Vice President for Scientific Communications at Alkermes, Inc. Concurrently, A. Thomas McLellan, Ph.D., founder of the Treatment…
Read More

Treatment Research Institute Partners with Top Addiction Specialists to Teach Substance Use Disorders to Medical Students

Philadelphia, PA (Aug. 7, 2014) – Treatment Research Institute (TRI) has collaborated with the Hazelden Betty Ford Foundation (HBFF), the American Society of Addiction Medicine (ASAM) and MedU to help prepare physicians to address the growing problem of substance use disorders and addiction facing society and the health care system. Medical education has rarely included…
Read More